FALCO HOLDINGS (4671) Fundamentals 2026 — P/E 13.4x, Revenue Analysis | SniperIQ
FALCO HOLDINGS (4671) is a JP-listed Healthcare company in Medical - Diagnostics & Research with a market capitalization of ¥27.0B, trading at ¥2695.00 on the JPX. This SniperIQ fundamentals page covers FALCO HOLDINGS's valuation (P/E 13.4x, P/B 1.0x), profitability (net margin 4.6%), revenue (¥43.6B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is FALCO HOLDINGS's market cap?
FALCO HOLDINGS (4671) has a market capitalization of approximately ¥27.0B, trading at ¥2695.00 on the JPX. Market cap moves with the live share price.
What is FALCO HOLDINGS's P/E ratio?
FALCO HOLDINGS's trailing twelve-month P/E ratio is 13.4x, with a price-to-book (P/B) of 1.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is FALCO HOLDINGS?
FALCO HOLDINGS runs a net profit margin of 4.6%, a gross margin of 31.7%, and an operating margin of 5.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does FALCO HOLDINGS generate?
FALCO HOLDINGS reported revenue of ¥43.6B for fiscal year 2025, with net income of ¥2.0B and earnings per share (EPS) of 201.04. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does FALCO HOLDINGS pay a dividend?
FALCO HOLDINGS offers a trailing dividend yield of about 4.6%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is FALCO HOLDINGS financially healthy?
FALCO HOLDINGS carries a debt-to-equity ratio of 0.05x and a current ratio of 2.37x, with a market beta of 0.27. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is FALCO HOLDINGS a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For FALCO HOLDINGS (4671) the key facts are: market cap ¥27.0B, P/E 13.4x, revenue ¥43.6B, 52-week range 2293-2775. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track FALCO HOLDINGS's full fundamentals live
Get FALCO HOLDINGS's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.